Christopher Dvorak Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

1/2020

Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Dvorak Research Topics

Disease

3	Leukemia 01/2021 - 05/2014
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 05/2014
2	Neoplasms (Cancer) 01/2021 - 12/2018
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Residual Neoplasm 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Sepsis (Septicemia) 01/2020
1	Infections 01/2020
1	Pediatric Obesity 05/2014
1	Enterocolitis 03/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2011

Drug/Important Bio-Agent (IBA)

2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 05/2014
1	Busulfan (Busulfex)FDA Link 01/2022
1	Vincristine (Oncovin)FDA LinkGeneric 01/2021
1	Interleukin-10 (Interleukin 10)IBA 03/2013
1	Interleukin-10 ReceptorsIBA 03/2013

Therapy/Procedure

5	Cell Transplantation 01/2022 - 12/2011
1	Transplantation 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Therapeutics 01/2021
1	Indwelling Catheters (Indwelling Catheter) 01/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 05/2014